Characterization of co-purified acellular pertussis vaccines

References

• Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glode MP, Ehresmann KR. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116:e285-94; PMID:16061582; http://dx.doi.org/10.1542/peds.2004-2759
   PubMedGoogle Scholar
• Wang L, Lei D, Zhang S. Acellular pertussis vaccines in China. Vaccine 2012; 30:7174-8; PMID:23084855; http://dx.doi.org/10.1016/j.vaccine.2012.10.009.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Department of vaccine and biological. Pertussis surveillance. A global meeting. WHO/V&B/01.19. Geneva, 2001
   Google Scholar
• Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 1997; 100:772-88; PMID:9346976; http://dx.doi.org/10.1542/peds.100.5.772
   PubMed Web of Science ®Google Scholar
• Stewart GT. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83. Dev Biol Stand 1985; 61:395-405; PMID:3835080
   PubMedGoogle Scholar
• Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1984; 1:122-6; PMID:6140441; http://dx.doi.org/10.1016/S0140-6736(84)90061-8
   PubMed Web of Science ®Google Scholar
• Zhu F. Pertussis booster vaccine in China. Hum Vaccin 2011; 7:272-5; PMID:21307651; http://dx.doi.org/10.4161/hv.7.2.13861
   PubMed Web of Science ®Google Scholar
• He CM, Yang XM, Wang ZS, Qin L, Sun SX. A Phase III clinical trial on immunization reaction and serological effect of adsorbed acellular pertussis vaccine-diphtheria and tetanus toxoid combined vaccine. Prog Microbiol Immunol 2006; 26:25-8.
   Google Scholar
• Zhang JM, Wang Y, Xiao ZR, Li WC, Yang JF, Zhou YC, Fu HL, Ding ZS, Hou QM, Guan Yi, et al. Characteristic and clinical observation of APDT prepared with acellular pertussis vaccine. J Chin Biol 1993; 6:131-6; PMID:NOT_FOUND
   PubMedGoogle Scholar
• Kmietowicz Z. Pertussis cases rise 10-fold among older children and adults in England and Wales. BMJ 2012; 345:e5008; PMID:22826583; http://dx.doi.org/10.1136/bmj.e5008
   PubMedGoogle Scholar
• Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012; 129:968-70; PMID:22529282; http://dx.doi.org/10.1542/peds.2011-2594
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012; 367:1012-9; PMID:22970945; http://dx.doi.org/10.1056/NEJMoa1200850
   PubMed Web of Science ®Google Scholar
• Konda T MYPMoHaW, National Institute of health, Japan. Annual report 1995 National Epidemiological Surveillance of Vaccine-Preventable Diseases. 1997; 69-90 ( English version: http://idsc.nih.go.jp/index.html)
   Google Scholar
• National Institute of Infectious Diseases IDCD, Ministry of Health and Welfare, Japan. Pertussis. 1982-1996. Infectious Agents Surveillance report 1997; 18:101-2 (http://idsc.nih.go.jp/iasr/18/207/tpc207.html)
   Google Scholar
• Horiuchi Y, Takahashi M, Konda T, Ochiai M, Yamamoto A, Kataoka M, Toyoizumi H, Arakawa Y. Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan. Jpn J Infect Dis 2001; 54:167-80; PMID:11754154
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65:2168-74; PMID:9169747
   PubMed Web of Science ®Google Scholar
• Mills KH, Ryan M, Ryan E, Mahon BP. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 1998; 66:594-602; PMID:9453614
   PubMed Web of Science ®Google Scholar
• Mascart F, Hainaut M, Peltier A, Verscheure V, Levy J, Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 2007; 25:391-8; PMID:17116347; http://dx.doi.org/10.1016/j.vaccine.2006.06.046
   PubMed Web of Science ®Google Scholar
• Poland GA. Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations? Vaccine 2012; 30:6957-9; PMID:23141958; http://dx.doi.org/10.1016/j.vaccine.2012.09.084
   PubMed Web of Science ®Google Scholar
• Fisman DN, Tang P, Hauck T, Richardson S, Drews SJ, Low DE, Jamieson F. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 2011; 11:694; PMID:21899765; http://dx.doi.org/10.1186/1471-2458-11-694
   PubMed Web of Science ®Google Scholar
• World Health Organization. Geneva: Programmes and projects/Immunization surveillance, assessment and monitoring/Vaccine-preventable diseases/Pertussis. Available at: (http://www.who.int/immunization_monitoring/diseases/pertussis/en/index.html)
   Google Scholar
• Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013; 56:1248-54; PMID:23487373; http://dx.doi.org/10.1093/cid/cit046
   PubMed Web of Science ®Google Scholar
• Lopez JL. Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 849:190-202; PMID:17188947; http://dx.doi.org/10.1016/j.jchromb.2006.11.049
   PubMed Web of Science ®Google Scholar
• Altindis E, Tefon BE, Yildirim V, Ozcengiz E, Becher D, Hecker M, Ozcengiz G. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 2009; 27:542-8; PMID:19028538; http://dx.doi.org/10.1016/j.vaccine.2008.11.020
   PubMed Web of Science ®Google Scholar
• Vidakovics ML, Paba J, Lamberti Y, Ricart CA, de Sousa MV, Rodriguez ME. Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 2007; 6:2518-28; PMID:17523612; http://dx.doi.org/10.1021/pr060681i
   PubMedGoogle Scholar
• Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernandez J, Sisti F, Graieb A, Roberts R, Rico O, Rios G, et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 2007; 14:1490-8; PMID:17699837; http://dx.doi.org/10.1128/CVI.00177-07
   PubMedGoogle Scholar
• Canthaboo C, Williams L, Xing DK, Corbel MJ. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine 2000; 19:637-43; PMID:11090715; http://dx.doi.org/10.1016/S0264-410X(00)00253-X
   PubMed Web of Science ®Google Scholar
• Redhead K, Watkins J, Barnard A, Mills KH. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993; 61:3190-8; PMID:8335349
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Lande R, Urbani F, la Sala A, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun 1999; 67:4064-71; PMID:10417175
   PubMed Web of Science ®Google Scholar
• Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264; PMID:23592988; http://dx.doi.org/10.1371/journal.ppat.1003264
   PubMed Web of Science ®Google Scholar
• Coleman MM, Finlay CM, Moran B, Keane J, Dunne PJ, Mills KH. The immunoregulatory role of CD4(+) FoxP3(+) CD25(-) regulatory T cells in lungs of mice infected with Bordetella pertussis. FEMS Immunol Med Microbiol 2012; 64:413-24; PMID:22211712; http://dx.doi.org/10.1111/j.1574-695X.2011.00927.x
   PubMed Web of Science ®Google Scholar
• Barnard A, Mahon BP, Watkins J, Redhead K, Mills KH. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996; 87:372-80; PMID:8778021; http://dx.doi.org/10.1046/j.1365-2567.1996.497560.x
   PubMedGoogle Scholar
• Xing DK, Das RG, Williams L, Canthaboo C, Tremmil J, Corbel MJ. An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines. Vaccine 1999; 17:565-76; PMID:10075163; http://dx.doi.org/10.1016/S0264-410X(98)00235-7
   PubMed Web of Science ®Google Scholar
• Church MA. Evidence of whooping-cough-vaccine efficacy from the 1978 whooping-cough epidemic in Hertfordshire. Lancet 1979; 2:188-90; PMID:89292; http://dx.doi.org/10.1016/S0140-6736(79)91447-8
   PubMedGoogle Scholar
• Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 area health authorities. Br Med J (Clin Res Ed) 1982; 285:357-9; PMID:6284296; http://dx.doi.org/10.1136/bmj.285.6338.357
   PubMedGoogle Scholar
• Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad hoc group for the study of pertussis vaccines. Lancet 1997; 350:1569-77; PMID:9393335; http://dx.doi.org/10.1016/S0140-6736(97)06508-2
   PubMed Web of Science ®Google Scholar
• Fuchslocher B, Millar LL, Cotter PA. Comparison of bipA alleles within and across Bordetella species. Infect Immun 2003; 71:3043-52; PMID:12761081; http://dx.doi.org/10.1128/IAI.71.6.3043-3052.2003
   PubMedGoogle Scholar
• Deora R, Bootsma HJ, Miller JF, Cotter PA. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene. Mol Microbiol 2001; 40:669-83; PMID:11359572; http://dx.doi.org/10.1046/j.1365-2958.2001.02415.x
   PubMed Web of Science ®Google Scholar
• Coutte L, Antoine R, Drobecq H, Locht C, Jacob-Dubuisson F. Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J 2001; 20:5040-8; PMID:11566869; http://dx.doi.org/10.1093/emboj/20.18.5040
   PubMed Web of Science ®Google Scholar
• Zhu YZ, Cai CS, Zhang W, Guo HX, Zhang JP, Ji YY, Ma GY, Wu JL, Li QT, Lu CP, et al. Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV). PLoS One 2010; 5:e13915; PMID:21170113; http://dx.doi.org/10.1371/journal.pone.0013915
   PubMedGoogle Scholar
• Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20:3551-67; PMID:10612281; http://dx.doi.org/10.1002/(SICI)1522-2683(19991201)20:18%3c3551::AID-ELPS3551%3e3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Gardy JL, Spencer C, Wang K, Ester M, Tusnady GE, Simon I, Hua S, deFays K, Lambert C, Nakai K, et al. PSORT-B: improving protein subcellular localization prediction for Gram-negative bacteria. Nucleic Acids Res 2003; 31:3613-7; PMID:12824378; http://dx.doi.org/10.1093/nar/gkg602
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Recommendations to assure the quality, safety and efficacy of Acellular Pertussis Vaccines, Annex 4, Technical Report Series 979. Geneva, 2009. Available at: (http://www.who.int/biologicals/vaccines/TRS_979_Annex_4.pdf?ua=1)
   Google Scholar
• Gaines-Das R, Horiuchi Y, Zhang SM, Newland P, Kim Y, Corbel M, Xing D. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Vaccine 2009; 27:6824-32; PMID:19765397; http://dx.doi.org/10.1016/j.vaccine.2009.09.014
   PubMed Web of Science ®Google Scholar